SCHEMBL31309092

SCHEMBL31309092

CCOC(=O)[C@@H]1C[C@H](O[Si](C)(C)C(C)(C)C)CN1Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
ALDH1A1 P00352 5/20 0.41
KDM4E B2RXH2 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
POLB P06746 1/20 0.41
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
CHRM5 P08912 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
PDK1 Q15118 1/20 0.39
PDK2 Q15119 1/20 0.39
PDK3 Q15120 1/20 0.39
PDK4 Q16654 1/20 0.39
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8833545 0.89 CHRM2 (0.41) KMT2AALDH1A1KDM4ECHRM2CHRM4
SCHEMBL18387515 0.89 CHRM2 (0.41) KMT2AALDH1A1KDM4ECHRM2CHRM4
SCHEMBL9220238 0.89 CHRM2 (0.41) KMT2AALDH1A1KDM4ECHRM2CHRM4
SCHEMBL19408441 0.89 CHRM2 (0.41) KMT2AALDH1A1KDM4ECHRM2CHRM4
SCHEMBL1444237 0.89 CHRM2 (0.41) KMT2AALDH1A1KDM4ECHRM2CHRM4
SCHEMBL19465331 0.88 CHRM2 (0.43) MEN1KMT2ACHRM2CHRM4CHRM5
SCHEMBL28593949 0.88 CHRM2 (0.43) MEN1KMT2ACHRM2CHRM4CHRM5
SCHEMBL1439745 0.88 CHRM2 (0.43) MEN1KMT2ACHRM2CHRM4CHRM5
SCHEMBL29940175 0.84 CHRM2 (0.41) MEN1KMT2ACHRM2CHRM4CHRM5
SCHEMBL16023506 0.80 MAPT (0.52) CHRM2CHRM4CHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4735433-A2 SUBSTITUTED PYRIDAZINE COMPOUNDS AS INHIBITORS OF NLRP3 ACTIVITY AND THERAPEUTIC USES THEREOF Viva Star Biosciences (US) Inc. (US) 2026-05-06 EP disclosed
WO-2025006681-A2 SUBSTITUTED PYRIDAZINE COMPOUNDS AS INHIBITORS OF NLRP3 ACTIVITY AND THERAPEUTIC USES THEREOF VIVA STAR BIOSCIENCES (US) INC. (US) 2025-01-02 WO disclosed